Timothy I. Still

Timothy Still is the current CEO of Sense Biodetection. Prior to that, they were an executive advisor at JLL Partners from January 2019 to December 2021. Timothy has also served as a non-executive board member at MDxHealth from January 2019 to December 2021, and as the CEO, President, and Board Member of Global Kinetics from January 2016 to December 2017. In 2018, they became the CEO, President, and Board Member of iovera° / Pacira, which was acquired by Pacira Biosciences in 2019. Timothy also served as the Executive Chairman & Board Member of Gold Standard Diagnostics / Eurofins from January 2014 to December 2018, and as the CEO, President & Board Member of Xagenic Inc. / General Atomics from January 2014 to December 2016.

Ryan Roberts - Chief Commercial Officer, Michael Jones - CFO, and Dan Delaney - VP, Clinical & Regulatory Operations report to Timothy I. Still.